StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3056% below fair value
$12.19−0.35 (-2.79%)

Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%

Medifast total assets

Total assets on the balance sheet at the end of each period.

Medifast's total assets was $239.76M at Sep 30, 2026. For fiscal 2025 it was $247.97M, down 12.8% from the year before. Over ten years it grew 7.9% a year on average. The highest annual figure on record is $398.33M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$247.97M-12.8%
FY2024Dec 31, 2024$284.21M-8.3%
FY2023Dec 31, 2023$309.91M-2.0%
FY2022Dec 31, 2022$316.21M-20.6%
FY2021Dec 31, 2021$398.33M+44.3%
FY2020Dec 31, 2020$276.08M+41.8%
FY2019Dec 31, 2019$194.65M+14.9%
FY2018Dec 31, 2018$169.43M+16.1%
FY2017Dec 31, 2017$145.93M+20.4%
FY2016Dec 31, 2016$121.22M+4.4%
FY2015Dec 31, 2015$116.12M+0.2%
FY2014Dec 31, 2014$115.91M-12.6%
FY2013Dec 31, 2013$132.65M+1.8%
FY2012Dec 31, 2012$130.25M+23.3%
FY2011Dec 31, 2011$105.67M+12.3%
FY2010Dec 31, 2010$94.06M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$239.76M-10.6%
Q2 FY2026Jun 30, 2026$260.40M-3.3%
Q1 FY2026Mar 31, 2026$252.05M-10.0%
Q4 FY2025Dec 31, 2025$247.97M-12.8%
Q3 FY2025Sep 30, 2025$268.21M-7.9%
Q2 FY2025Jun 30, 2025$269.33M-8.2%
Q1 FY2025Mar 31, 2025$280.01M-7.5%
Q4 FY2024Dec 31, 2024$284.21M-8.3%
Q3 FY2024Sep 30, 2024$291.24M-9.0%
Q2 FY2024Jun 30, 2024$293.53M-7.9%
Q1 FY2024Mar 31, 2024$302.76M-5.9%
Q4 FY2023Dec 31, 2023$309.91M-2.0%
Q3 FY2023Sep 30, 2023$320.02M-1.9%
Q2 FY2023Jun 30, 2023$318.73M-6.4%
Q1 FY2023Mar 31, 2023$321.61M-23.7%
Q4 FY2022Dec 31, 2022$316.21M-20.6%
Q3 FY2022Sep 30, 2022$326.35M-12.1%
Q2 FY2022Jun 30, 2022$340.55M-6.5%
Q1 FY2022Mar 31, 2022$421.44M+29.1%
Q4 FY2021Dec 31, 2021$398.33M+44.3%
Q3 FY2021Sep 30, 2021$371.37M+42.4%
Q2 FY2021Jun 30, 2021$364.23M+56.9%
Q1 FY2021Mar 31, 2021$326.40M+61.5%
Q4 FY2020Dec 31, 2020$276.08M+41.8%
Q3 FY2020Sep 30, 2020$260.79M+31.3%
Q2 FY2020Jun 30, 2020$232.09M+9.2%
Q1 FY2020Mar 31, 2020$202.14M-3.8%
Q4 FY2019Dec 31, 2019$194.65M+14.9%
Q3 FY2019Sep 30, 2019$198.59M+13.8%
Q2 FY2019Jun 30, 2019$212.57M+36.0%
Q1 FY2019Mar 31, 2019$210.07M+38.4%
Q4 FY2018Dec 31, 2018$169.43M+16.1%
Q3 FY2018Sep 30, 2018$174.45M+29.7%
Q2 FY2018Jun 30, 2018$156.31M+20.7%
Q1 FY2018Mar 31, 2018$151.82M+23.5%
Q4 FY2017Dec 31, 2017$145.93M+20.4%
Q3 FY2017Sep 30, 2017$134.46M–
Q2 FY2017Jun 30, 2017$129.52M–
Q1 FY2017Mar 31, 2017$122.95M–
Q4 FY2016Dec 31, 2016$121.22M–

More Medifast figures

See a number that looks wrong?